Katsutoshi Terasawa Selected Research

keishibukuryogan

12/2008	A Proteomic Approach for the Diagnosis of 'Oketsu' (blood stasis), a Pathophysiologic Concept of Japanese Traditional (Kampo) Medicine.
10/2007	Identification of a predictive biomarker for the beneficial effect of a Kampo (Japanese traditional) medicine keishibukuryogan in rheumatoid arthritis patients.
2/2005	Oren-gedoku-to and Keishi-bukuryo-gan-ryo inhibit the progression of atherosclerosis in diet-induced hypercholesterolemic rabbits.
2/2003	Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy.
9/2002	Keishi-bukuryo-gan preserves the endothelium dependent relaxation of thoracic aorta in cholesterol-fed rabbit by limiting superoxide generation.
6/2002	Inhibitory effects of Keishi-bukuryo-gan on free radical induced lysis of rat red blood cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katsutoshi Terasawa Research Topics

Disease

6	Hemolysis 05/2005 - 06/2002
5	Rheumatoid Arthritis 12/2008 - 08/2003
3	Human Influenza (Influenza) 01/2008 - 12/2002
3	Atherosclerosis 02/2005 - 06/2002
2	Pain (Aches) 06/2011 - 02/2011
2	Non-alcoholic Fatty Liver Disease 03/2008 - 10/2006
2	Inflammation (Inflammations) 01/2007 - 09/2006
2	Cough 09/2006 - 06/2006
2	Ischemia 12/2004 - 09/2004
2	Chronic Hepatitis C 06/2004 - 01/2002
2	Diabetic Nephropathies (Diabetic Nephropathy) 02/2003 - 01/2003
2	Proteinuria 02/2003 - 01/2003
1	Breast Neoplasms (Breast Cancer) 01/2014
1	Lymphangioma (Cavernous Lymphangioma) 06/2011
1	Contact Dermatitis (Eczema, Contact) 06/2011
1	Nausea 06/2011
1	Somatoform Disorders (Somatoform Disorder) 02/2011
1	Medically Unexplained Symptoms 02/2011
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2011
1	Drug-Related Side Effects and Adverse Reactions 01/2011
1	Atopic Dermatitis (Atopic Eczema) 01/2010
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2008
1	Alcoholic Fatty Liver 03/2008
1	Fatty Liver 10/2006
1	Body Weight (Weight, Body) 10/2006
1	Fibrosis (Cirrhosis) 10/2006
1	Common Cold 09/2006
1	Chronic Disease (Chronic Diseases) 10/2005
1	Fatigue 10/2005
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2005
1	Atherosclerotic Plaque (Atheroma) 02/2005
1	Hypercholesterolemia 02/2005
1	Virus Diseases (Viral Diseases) 01/2005
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 09/2004
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 02/2003
1	Hypertension (High Blood Pressure) 02/2003
1	Gastritis 02/2003
1	Liver Diseases (Liver Disease) 02/2003
1	Stroke (Strokes) 01/2003
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2003
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2003
1	Agoraphobia 12/2002
1	Pneumonia (Pneumonitis) 12/2002

Drug/Important Bio-Agent (IBA)

6	keishibukuryoganIBA 12/2008 - 06/2002
5	2,2'-azobis(2-amidinopropane) (ABAP)IBA 05/2005 - 06/2002
4	CholesterolIBA 10/2006 - 06/2002
3	AntioxidantsIBA 04/2005 - 12/2004
3	choto-sanIBA 12/2004 - 01/2003
3	Free RadicalsIBA 02/2003 - 06/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008 - 08/2002
2	Citric Acid (Citrate)FDA LinkGeneric 09/2006 - 06/2006
2	Antitussive Agents (Antitussives)FDA Link 09/2006 - 06/2006
2	oren gedoku toIBA 02/2005 - 02/2003
2	Messenger RNA (mRNA)IBA 01/2005 - 12/2002
2	Mao-toIBA 06/2004 - 01/2002
2	InterferonsIBA 06/2004 - 01/2002
2	SuspensionsIBA 02/2003 - 06/2002
2	Plant ExtractsIBA 01/2003 - 12/2002
1	Paroxetine (Paxil)FDA LinkGeneric 06/2011
1	HaptensIBA 06/2011
1	etizolamIBA 06/2011
1	keishi-ka-jutsubu-toIBA 02/2011
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2011
1	juzentaihotoIBA 01/2010
1	Glucose (Dextrose)FDA LinkGeneric 03/2008
1	LipidsIBA 03/2008
1	AdipokinesIBA 03/2008
1	Conditioned Culture MediaIBA 01/2008
1	Biomarkers (Surrogate Marker)IBA 10/2007
1	KIR ReceptorsIBA 01/2007
1	Immunoglobulin M (IgM)IBA 01/2007
1	cyclic citrullinated peptideIBA 01/2007
1	Insulin (Novolin)FDA Link 10/2006
1	Pseudoephedrine FDA LinkGeneric 09/2006
1	Nasal Decongestants (Decongestants)IBA 09/2006
1	Ephedrae herbaIBA 06/2006
1	SolutionsIBA 06/2006
1	Codeine (Codeine Phosphate)FDA LinkGeneric 06/2006
1	Fish OilsIBA 03/2005
1	Vitamin E FDA LinkGeneric 02/2005
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2005
1	Ether (Diethyl Ether)IBA 01/2005
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2005
1	Superoxides (Superoxide)IBA 12/2004
1	EnzymesIBA 12/2004
1	Hydroxyl RadicalIBA 12/2004
1	Neuroprotective AgentsIBA 09/2004
1	Drinking WaterIBA 09/2004
1	AA amyloidosisIBA 08/2003
1	Urea (Carbamide)FDA LinkGeneric 02/2003
1	NitrogenIBA 02/2003
1	CreatinineIBA 02/2003
1	gosha-jinki-ganIBA 01/2003
1	Complementary DNA (cDNA)IBA 12/2002

Therapy/Procedure

17	Kampo Medicine (Kampo) 06/2011 - 01/2002
3	Oral Administration 12/2004 - 01/2003
2	Therapeutics 02/2011 - 10/2005
2	Intraperitoneal Injections 09/2006 - 06/2006
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2014
1	Traditional Medicine (Folk Remedies) 10/2007